17 news items
Reported Monday June 10, 2024 "Amneal, U.S. FTC Win Order Removing Teva Inhaler Patents From FDA List" - Reuters News
AMRX
TEVA
11 Jun 24
://www.reuters.com/legal/litigation/amneal-us-ftc-win-order-removing-teva-inhaler-patents-fda-list-2024-06-10/ Drugmaker Amneal
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
TEVA
4 Jun 24
of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA
1 Jun 24
Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA
1 Jun 24
statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA
29 May 24
of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject
akrgastgk689kyzs5ud5ewi
ALVO
TEVA
20 May 24
the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject
2othbwusgvdv
TEVA
15 May 24
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based
cuflyhc0k7682q9bz69hblo2x2j uqbhjlk
TEVA
8 May 24
of 2023, mainly due to lower litigation fees in the first quarter of 2024
k77b7yijk g28vu9lm5qy
TEVA
8 May 24
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
wufwvc152sb9nf fu82qf87sbiz5
TEVA
2 May 24
of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks
60yeh9e0mzimvusuflhrrqpbvnjz4gl6u93hhh2eg46m7fna
TEVA
2 May 24
Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's
5nrri9hn0s2yj bjah3b
AMPH
AZN
NVO
1 May 24
, potentially leading to post-approval patent litigation.
Additionally, some critics attribute part of the problem to the U.S. Patent
j2684w55wfb9ckpm7upgca g7hl8cs3s6vy7jsdm5
ALVO
TEVA
30 Apr 24
in this communication may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward
piy9jyub4joff19tg2kwx6lta683tgrv
TEVA
11 Apr 24
the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject
d7y9rr7jai0bjw97lme0dftnfcec02nh714tce6l6y59q0c
TEVA
9 Apr 24
statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations
y1a9poihojfcdel1blwu5jn0k9ogeyuki1we9f4
TEVA
6 Apr 24
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
g3dp0rr6pcmyd9yhozb2hjrzchfsrhk99ez16rhz9gm6cn6jtxet
TEVA
4 Apr 24
of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject
- Prev
- 1
- Next